[go: up one dir, main page]

ES439113A1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ES439113A1
ES439113A1 ES439113A ES439113A ES439113A1 ES 439113 A1 ES439113 A1 ES 439113A1 ES 439113 A ES439113 A ES 439113A ES 439113 A ES439113 A ES 439113A ES 439113 A1 ES439113 A1 ES 439113A1
Authority
ES
Spain
Prior art keywords
skin
compatible
tenside
pharmaceutical compositions
lysage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES439113A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES439113A1 publication Critical patent/ES439113A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Procedure for preparing pharmaceutical products for penetration through the skin, characterized in that at least one pharmacological active agent, such as a lysage acid derivative, a quinazolinone or a calcitonin, is partially dissolved in a mixture of support material that it is composed of at least one superior aliphatic alcohol, compatible with the skin, with at least one anionic and/or amphoteric tenside, compatible with the skin, with a pH of 4-8 in aqueous medium, the total amount of the tenside rising to at least 5% by weight of the total composition. (Machine-translation by Google Translate, not legally binding)
ES439113A 1974-07-05 1975-07-03 Pharmaceutical compositions Expired ES439113A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (1)

Publication Number Publication Date
ES439113A1 true ES439113A1 (en) 1977-10-16

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES439113A Expired ES439113A1 (en) 1974-07-05 1975-07-03 Pharmaceutical compositions

Country Status (14)

Country Link
JP (1) JPS5132724A (en)
AU (1) AU8280175A (en)
BE (1) BE831042A (en)
DE (1) DE2528516A1 (en)
ES (1) ES439113A1 (en)
FR (1) FR2276832A1 (en)
GB (1) GB1518683A (en)
HU (1) HU170215B (en)
IL (1) IL47634A (en)
NL (1) NL7507798A (en)
NZ (1) NZ178011A (en)
SE (1) SE7507414L (en)
YU (1) YU170475A (en)
ZA (1) ZA754304B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
FR2483235A1 (en) * 1980-05-28 1981-12-04 Fabre Sa Pierre TOPICAL COMPOSITIONS CONTAINING RYE AND VINCA ROSEA ERGOT ALKALOIDS FOR THE TREATMENT OF HYPERSEBORRHOES
JPS59216825A (en) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd External drug for transcutaneous absorption
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
JPS6013720A (en) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (en) * 1986-01-16 1995-04-19 久光製薬株式会社 External gel formulation
JPH0735332B2 (en) * 1986-02-25 1995-04-19 久光製薬株式会社 Cream formulation for external use
JPH0759519B2 (en) * 1987-02-23 1995-06-28 株式会社資生堂 Transdermal absorption enhancer and external preparation for skin containing the same
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE3710216A1 (en) * 1987-03-27 1988-10-06 Rentschler Arzneimittel USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
JPH0720866B2 (en) * 1987-05-15 1995-03-08 三生製薬株式会社 Transdermal preparation containing eperisone or tolperisone or their salts
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (en) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
ATE164080T1 (en) * 1990-05-10 1998-04-15 Bechgaard Int Res PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETHYLENE GLYCOLS
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
DE69429822T2 (en) * 1993-11-12 2002-11-28 The Procter & Gamble Company, Cincinnati DETERMINING COMPOSITION OF SALICYLIC ACID AND ZWITTERIONIC COMPOUNDS
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
PT1666026E (en) † 1999-02-08 2012-03-15 Intarcia Therapeutics Inc Non-aqueous single phase biocompatible viscous vehicles and methods for preparing the same
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
JP5143131B2 (en) 2006-05-30 2013-02-13 インターシア セラピューティクス，インコーポレイティド Two-piece internal channel flow modulator for osmotic delivery system
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
CN101715340A (en) 2007-04-23 2010-05-26 精达制药公司 Suspension formulation of insulinotropic peptide and application thereof
EP3011954A1 (en) * 2007-11-22 2016-04-27 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
US8343140B2 (en) 2008-02-13 2013-01-01 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
KR102093612B1 (en) 2009-09-28 2020-03-26 인타르시아 세라퓨틱스 인코포레이티드 Rapid establishment and/or termination of substantial steady-state drug delivery
JP2012020991A (en) 2010-06-16 2012-02-02 Takasago Internatl Corp Transdermal absorption promoter, and external skin formulation thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820206B2 (en) 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
JP5820207B2 (en) * 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3395369A1 (en) 2014-10-30 2018-10-31 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
RU2760007C2 (en) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Polypeptides selective to glucagon receptors and their application methods
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CA3049034A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug

Also Published As

Publication number Publication date
DE2528516A1 (en) 1976-01-22
AU8280175A (en) 1977-01-13
NZ178011A (en) 1978-07-28
HU170215B (en) 1977-04-28
NL7507798A (en) 1976-01-07
SE7507414L (en) 1976-01-07
BE831042A (en) 1976-01-05
FR2276832A1 (en) 1976-01-30
GB1518683A (en) 1978-07-19
IL47634A (en) 1978-07-31
ZA754304B (en) 1977-02-23
FR2276832B1 (en) 1978-10-06
IL47634A0 (en) 1975-10-15
JPS5132724A (en) 1976-03-19
YU170475A (en) 1984-02-29

Similar Documents

Publication Publication Date Title
ES439113A1 (en) Pharmaceutical compositions
SE8303531D0 (en) PHARMACEUTICAL COMPOSITION
GB1405088A (en) Slow release formulation
HU173557B (en) Process for producing 3-amino-indazolecarboxylic acid derivatives and pharmaceutical compositions containing the as active agents
ES444558A1 (en) Production of long acting insulin preparations
ES460743A1 (en) Preserving liquid antacid medicinal formulations
GB1298494A (en) Phenylethanolamine derivatives
GB1215256A (en) Pyran derivatives and their use in perfume compositions
DE3063858D1 (en) Process for the production of a solid form containing a pharmaceutical active agent or a diagnostic
ES458123A1 (en) Adenine derivatives and hypolipidemic composition thereof
ES415753A1 (en) Oral preparations
ES370058A1 (en) PROCEDURE FOR THE PREPARATION OF EFFERVESCENT PHARMACEUTICAL COMPOSITIONS.
AT382076B (en) METHOD FOR THE PRODUCTION OF PRESSURES WITH RETARDED ACTIVE SUBSTANCE RELEASE
ES434431A1 (en) PROCEDURE FOR PREPARING XANTHENE DERIVATIVES.
ES451880A1 (en) Toothpaste compostion
ES403972A1 (en) Moulded pharmaceutical compositions
ES395254A1 (en) Clear liquid laxative-antacid composition
ES398108A1 (en) Pharmaceutical composition
ES396666A1 (en) Toothpaste composition
GB1354263A (en) Therapeutic composition
FR2290203B1 (en)
ES419603A1 (en) Pharmaceutical preparations containing pyrazolones
GB1338808A (en) Thermoplastic compositions
ES294928A1 (en) A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding)
ES421570A1 (en) Reduction of serum lipid levels, and agents and compositions useful therefor